35205 Deucravacitinib improves Dermatology Life Quality Index (DLQI) in patients with moderate to severe psoriasis: Results from the phase 3 POETYK PSO-1 and PSO-2 trials

Journal of the American Academy of Dermatology(2022)

引用 0|浏览4
暂无评分
关键词
severe psoriasis,dermatology life quality index,deucravacitinib,dlqi
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要